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Abstract
We present a mathematical study of the emergence of phenotypic heterogeneity in vascularised tumours.
Our study is based on formal asymptotic analysis and numerical simulations of a system of non-local parabolic
equations that describes the phenotypic evolution of tumour cells and their nonlinear dynamic interactions
with oxygen, which is released from the intratumoural vascular network. Numerical simulations are carried
out both in the case of arbitrary distributions of intratumour blood vessels and in the case where the intra-
tumoural vascular network is reconstructed from clinical images obtained using dynamic optical coherence
tomography. The results obtained support a more in-depth theoretical understanding of the eco-evolutionary
process which underpins the emergence of phenotypic heterogeneity in vascularised tumours. In particular,
our results offer a theoretical basis for empirical evidence indicating that the phenotypic properties of cancer
cells in vascularised tumours vary with the distance from the blood vessels, and establish a relation between
the degree of tumour tissue vascularisation and the level of intratumour phenotypic heterogeneity.
1 Introduction
Spatial variability in the intratumoural concentration of oxygen plays a pivotal role in the emergence and
development of phenotypic heterogeneity among tumour cells [3, 40, 66, 69, 88]. This is exemplified in a growing
body of experimental and clinical studies demonstrating that tumour cells with different phenotypic properties
occupy tumour regions which are characterised by different oxygen levels. In particular, hypoxic parts of the
tumour (i.e. regions where oxygen levels are below normal physiological levels) are mainly populated by slow-
dividing cells, which display higher levels of hypoxia-inducible factors, such as HIF-1 [37, 55, 73, 81, 87, 89, 96].
On the other hand, fast-dividing cells with lower levels of expression of hypoxia-inducible factors are primarily
detected in well-oxygenated parts of the tumour tissue (i.e. the tumour border in avascular tumours and the
regions in the vicinity of blood vessels in vascularised tumours) [37, 89, 81].
This impinges on anti-cancer treatment by making impossible for single biopsies to exhaustively portray the
phenotypic composition of the whole tumour tissue [17, 76, 95].
Previous empirical and theoretical work has suggested that this may be the outcome of eco-evolutionary dy-
namics driven by interactions between oxygen molecules and tumour cells [3, 33, 36, 60, 66, 67]. In particular,
it has been hypothesised that the nonlinear interplay between impaired oxygen delivery caused by structural
abnormalities present in the tumour vasculature [32, 49, 50, 73, 91], limited oxygen diffusion and oxygen con-
sumption by tumour cells may lead to the creation of distinct ecological niches in which tumour cells with
different phenotypic characteristics can be selected [3, 19, 34, 44, 47, 59].
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In this paper, we use a spatially explicit phenotype-structured model to elucidate the eco-evolutionary dy-
namics that underpin the emergence of phenotypic heterogeneity in vascularised tumours. Building upon the
modelling framework that we developed in [62, 63], the model comprises a non-local parabolic partial differential
equation (PDE) that governs the local phenotypic distribution of cells within the tumour tissue. Similar PDEs
modelling the evolutionary dynamics of space- and phenotype-structured populations have recently received
increasing attention from the mathematical community – see for instance [1, 2, 9, 12, 13, 14, 18, 27, 45, 48, 68].
The equation for the evolution of the local phenotypic distribution of tumour cells is coupled with a parabolic
PDE that governs the local concentration of oxygen, whereby a spatially heterogeneous source term captures the
presence of intratumoural blood vessels which bring oxygen into the tumour tissue. Different possible definitions
of such a source term are considered, including definitions that are derived from clinical images obtained using
dynamic optical coherence tomography (D-OCT) [80] – i.e. a non-invasive imaging technique that enables the
visualisation of cutaneous microvasculature in 2D tissue sections with a width of and at a depth of up to several
millimetres [71].
Compared to previous related studies [62, 63], our model takes into account the effect of movement and phe-
notypic variation of tumour cells and, in addition, it does not rely on a quasi-stationary equilibrium assumption
for the oxygen concentration. Furthermore, while these previous studies are mainly focused on avascular tu-
mours, in this paper we consider vascularised tumours and systematically assess the impact of the density of
intratumoural blood vessels on the level of phenotypic heterogeneity of tumour cells, which is mathematically
quantified through suitable diversity indices. Moreover, numerical solutions of the model equations are here
integrated with the results of formal asymptotic analysis, in order to achieve more robust and precise biological
conclusions. Taken together, these elements of novelty widen considerably the range of application of the results
of our study and support a more in-depth theoretical understanding of the eco-evolutionary process which leads
to the emergence of phenotypic heterogeneity in vascularised tumours.
The paper is organised as follows. In Section 2, we introduce the equations of the model and the underlying
modelling assumptions. In Section 3, we carry out a formal asymptotic analysis of evolutionary dynamics. In
Section 4, we present a sample of numerical solutions that confirm the results of our formal analysis, and we
discuss their biological implications. Section 5 concludes the paper and provides a brief overview of possible
research perspectives.
2 Description of the model
We model the evolutionary dynamics of cancer cells in a region of a vascularised tumour that is approximated as
a bounded set Ω ⊂ Rd with smooth boundary ∂Ω, where d = 1, 2, 3 depending on the biological scenario under
study. The spatial position of the tumour cells is described by a vector r ∈ Ω, while the phenotypic state of
the cells is modelled by a scalar variable x ∈ [0, 1] ⊂ R, which represents the normalised level of expression of a
hypoxia-inducible factor. The phenotypic distribution of tumour cells at time t ≥ 0 and position r is described
by the function n(t, r, x), while the function s(t, r) describes the oxygen concentration at time t and position r.
At each time t, we define the local cell density and the local mean phenotypic state of tumour cells, respectively,
as
I(t, r) :=
∫ 1
0
n(t, r, x) dx and X(t, r) :=
1
I(t, r)
∫ 1
0
xn(t, r, x) dx. (1)
Moreover, we define the total cell number and the fraction of cells in the phenotypic state x within the tumour,
respectively, as
N(t) :=
∫
Ω
I(t, r) dr and F (t, x) :=
1
N(t)
∫
Ω
n(t, r, x) dr. (2)
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2.1 Dynamics of tumour cells
Tumour cells divide, die, move randomly (i.e. undergo undirected, spontaneous migration) and undergo sponta-
neous epimutations, that is, heritable phenotypic variations that occur randomly due to non-genetic instability
and are not induced by any selective pressure [46]. The dynamic of the local cell phenotypic distribution n(t, r, x)
is governed by the following boundary value problem subject to a suitable initial condition
∂tn = R
(
x, I(t, r), s(t, r)
)
n︸ ︷︷ ︸
cell division & death
+ α∂2xxn︸ ︷︷ ︸
spontaneous
epimutations
+ β∆rn︸ ︷︷ ︸
random
movement
in Ω,
I(t, r) :=
∫ 1
0
n(t, r, x) dx,
∂xn(·, ·, 0) = ∂xn(·, ·, 1) = 0,
∇rn · uˆ = 0 on ∂Ω,
(3)
where uˆ is the unit normal to ∂Ω that points outward from Ω.
The first diffusion term on the right-hand side of the non-local parabolic equation (3) describes the effect of
variations in the local phenotypic distribution due to spontaneous epimutations, which occur at rate α [22, 61].
The second diffusion term models the effect of cell random movement and the parameter β represents the
cell motility. The function R
(
x, I(t, r), s(t, r)
)
models the fitness of tumour cells in the phenotypic state x at
position r and time t under the local environmental conditions given by the cell density I(t, r) and the oxygen
concentration s(t, r) (i.e. the phenotypic fitness landscape of the tumour). In particular, we define the function
R as
R
(
x, I, s
)
:= p
(
x, s
)− κ I. (4)
Definition (4) models a biological scenario whereby tumour cells die at position r and time t due to competition
for limited space at rate κ I(t, r), with the parameter κ being related to the local carrying capacity of the
tumour. Moreover, the function p
(
x, s(t, r)
)
is the division rate of cells in the phenotypic state x at position r
and time t under the oxygen concentration s(t, r). Building upon the modelling strategy presented in [62], we
define the cell division rate as
p(x, s) := f(x) + g(x, s). (5)
In (5), the function g(x, s(t, r)) represents the rate of cell division via aerobic pathways under the oxygen
concentration s(t, r), while the function f(x) models the rate of cell division via anaerobic pathways. Based
on the biological evidence and ideas presented in [3, 7, 41, 59, 94], we let cells with a lower level of expression
of the hypoxia-inducible factor (i.e. cells in phenotypic states x → 0) be characterised by a higher rate of cell
division via aerobic pathways, while we assume cells with a higher level of expression of the hypoxia-inducible
factor (i.e. cells in phenotypic states x→ 1) to be characterised by a higher rate of cell division via anaerobic
pathways. Therefore, we assume the functions f(x) and g(x, s) to be smooth and such that
f(0) = 0, f ′(x) > 0 ∀x ∈ [0, 1), (6)
g(1, s) = 0 ∀ s ∈ [0,∞), ∂xg(x, s) < 0 ∀ (x, s) ∈ (0, 1]× (0,∞). (7)
Moreover, we make the following natural assumptions
g(x, 0) = 0 ∀x ∈ [0, 1], ∂sg(x, s) > 0 ∀ (x, s) ∈ [0, 1)× (0,∞). (8)
3
2.2 Dynamics of oxygen
We let oxygen enter the tumour through intratumoural blood vessels, diffuse in space, decay over time and
be consumed by tumour cells which divide via aerobic pathways. In this scenario, the dynamic of the oxygen
concentration s(t, r) is governed by the following boundary value problem
∂ts = βs∆rs︸ ︷︷ ︸
diffusion
− ηs
∫ 1
0
g(x, s)n(t, r, x) dx︸ ︷︷ ︸
consumption by tumour cells
− λss︸︷︷︸
decay
+ q(t, r)︸ ︷︷ ︸
inflow from
blood vessels
in Ω,
∇rs · uˆ = 0 on ∂Ω,
(9)
subject to a suitable initial condition and coupled to the non-local parabolic equation (3).
In the parabolic equation (9), the parameter βs is the oxygen diffusion coefficient, ηs is a conversion factor
linked to the rate of oxygen consumption by tumour cells, λs is the natural decay rate of oxygen, and the source
term q(t, r) models the influx of oxygen from the intratumoural blood vessels. We let ω ⊂ Ω be the set of points
within the tumour tissue which are occupied by blood vessels and, since we do not consider the formation of new
blood vessels, we assume ω to be given and remain constant in time. Therefore, we use the following definition
q(t, r) := S(t, r)1ω(r) (10)
where 1ω is the indicator function of the set ω and S(t, r) is the rate of inflow of oxygen through intratumoural
blood vessels at position r ∈ ω and time t.
Remark 1. In this paper, we do not take into account the effect of mechanical interactions between tumour
cells and blood vessels and we do not allow tumour cell to extravasate. Therefore, focussing on the case of
intratumoural blood vessels of small size, we implicitly make the following simplifying assumptions: (i) a point
r can be simultaneously occupied by blood vessels and tumour cells; (ii) cell movement is not affected by the
presence of blood vessels. Therefore, we do not impose any condition on n(t, r, x) in ω.
3 Formal analysis of evolutionary dynamics
In order to obtain an analytical description of the evolutionary dynamics of tumour cells, in this section we
carry out a formal asymptotic analysis of the behaviour of the solution to the boundary value problem (3) under
the assumption
s(t, r) ≡ s∞(r), (11)
where s∞(r) is a given smooth non-negative function. We note that assumptions (6)-(8) ensure that
0 < p(x, s) <∞ ∀ (x, s) ∈ [0, 1]× [0,∞). (12)
Moreover, in the case of an intratumour phenotypic fitness landscape R
(
x, I, s∞
)
defined according to (4) with
a single peak at each position r and time t, we let the cell division rate p be a smooth function that satisfies
the additional concavity assumption
∂2xxp(x, s) < 0 ∀ (x, s) ∈ [0, 1]× [0,∞). (13)
Typical values of the epimutation rate α are one or two orders of magnitude larger than the rate of somatic
DNA mutation [26, p.45], which is about 10−12s−1 [28], and typical values of the cell diffusivity β are about
10−12 cm2s−1 [85, 92]. Hence, spontaneous epimutations and random cell movement occur on slower time scales
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compared to cell division and death. To capture this fact, we introduce a small parameter ε > 0 and assume
both α := ε2 and β := ε2.
Following previous studies on the long-time behaviour of non-local PDEs and integro-differential equations
modelling the dynamics of continuously structured populations [11, 21, 24, 25, 48, 64, 68, 75], we use the time
scaling t 7→ tε in the conservation equation (3) complemented with (11), which gives the following non-local
PDE for the local cell phenotypic distribution n
(
t
ε , r, x
)
= nε(t, r, x)
ε ∂tnε = R
(
x, Iε(t, r), s
∞(r)
)
nε + ε
2 ∂2xxnε + ε
2 ∆rnε. (14)
Considering the asymptotic regime ε → 0 is equivalent to studying the behaviour of nε(t, r, x) over many cell
generations and in the case where spontaneous epimutations and random cell movement induce small changes
in the local phenotypic distribution.
Moreover, in agreement with much of the previous work on the mathematical analysis of the evolutionary
dynamics of continuously-structured populations [74], we consider the case where at time t = 0 tumour cells
that occupy the same position are mainly in the same phenotypic state, that is, at every position r the initial
local cell phenotypic distribution nε(0, r, x) is a sharp Gaussian-like function with mean value x¯
0(r) and integral
Iε(0, r). Hence, we assume
nε(0, r, x) = e
u0ε(r,x)/ε (15)
with u0ε(r, x) being a smooth, uniformly concave function of x for every r ∈ Ω such that
0 < Iε(0, r) <∞ (16)
and
eu
0
ε(r,x)/ε
∗−−−⇀
ε→0
I(0, r) δx¯0(r)(x) for all r ∈ Ω (17)
in the sense of measures, where δx¯0(r)(x) is the Dirac delta distribution centred at x¯
0(r).
Building upon the method presented in [11, 25, 64, 74, 75], we make the real phase WKB ansatz [10, 29, 30]
nε(t, r, x) = e
uε(t,r,x)/ε. (18)
Substituting this ansatz into (14) and noting that
∂tnε = ε
−1nε∂tuε, ∇rnε = ε−1nε∇ruε, ∂xnε = ε−1nε∂xuε,
∆rnε =
(
ε−1|∇ruε|
)2
nε + ε
−1nε∆ruε, ∂2xxnε =
(
ε−1∂xuε
)2
nε + ε
−1nε∂2xxuε,
we obtain
∂tuε = R
(
x, Iε(t, r), s
∞(r)
)
+ (∂xuε)
2 + |∇ruε|2 + ε
(
∂2xxuε + ∆ruε
)
(19)
subject to the initial condition uε(0, r, x) = u
0
ε(r, x), with u
0
ε(r, x) given by (15).
Letting ε→ 0 in (19) we formally obtain the following equation for the leading-order term u of the asymptotic
expansion for uε
∂tu = R(x, I(t, r), s
∞(r)) + (∂xu)2 + |∇ru|2, (20)
where I(t, r) is the leading-order term of the asymptotic expansion for Iε(t, r).
Since u0ε is a uniformly concave function of x and, under assumption (13), R is a concave function of x as
well, we expect u to be a concave function of x [11, 68, 75]. Therefore, we formally have that there exists a
unique locally dominant phenotypic state x¯(t, r), which is such that u(t, r, x¯(t, r)) = max
x∈[0,1]
u(t, r, x) and
∂xu(t, r, x¯(t, r)) = 0. (21)
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Moreover, (12) and (16) ensure that 0 < Iε(t, r) <∞ and, therefore, letting ε→ 0 in (18) gives the constraint
u(t, r, x¯(t, r)) = 0 for all (t, r) ∈ (0,∞)× Ω. (22)
Evaluating (20) at x = x¯(t, r) and using (21) along with (22) yields
R(x¯(t, r), I(t, r), s∞(r)) = 0. (23)
Differentiating (21) with respect to t yields
∂txu(t, r, x¯(t, r)) + ∂
2
xxu(t, r, x¯(t, r)) ∂tx¯(t, r) = 0
and, since we expect u to be a concave function of x [11, 68, 75], we can formally rewrite the above equation as
∂tx¯(t, r) = −(∂2xxu(t, r, x¯(t, r))−1∂txu(t, r, x¯(t, r)). (24)
Furthermore, differentiating both sides of (20) with respect to x, evaluating the resulting equation at x = x¯(t, r)
and using (21) along with (22) gives
∂txu(t, r, x¯(t, r)) = ∂xR
(
x¯(t, r), I(t, r), s∞(r)
)
.
Substituting the latter equation into (24) we formally obtain the following equation for x¯(t, r)
∂tx¯(t, r) = −(∂2xxu(t, r, x¯(t, r)))−1 ∂xR(x¯(t, r), I(t, r), s∞(r)). (25)
Combining (23) and (25) we find that the steady-state values of I(t, r) and x¯(t, r), say I∞(r) and x¯∞(r),
need to satisfy 
R(x¯∞(r), I∞(r), s∞(r)) = 0,
∂xR(x¯
∞(r), I∞(r), s∞(r)) = 0.
Substituting (4) into the above system of equations, we formally obtain

p(x¯∞(r), s∞(r))− κI∞(r) = 0,
∂xp(x¯
∞(r), s∞(r)) = 0,
=⇒

I∞(r) =
1
κ
p(x¯∞(r), s∞(r)),
x¯∞(r) = arg max
x∈[0,1]
p(x, s∞(r)).
(26)
Taken together, these formal results indicate that, in the framework of the assumptions considered in this
section, we can expect the steady-state local cell phenotypic distribution n∞(r, x) to be of the form
n∞(r, x) = I∞(r) δx¯∞(r)(x), (27)
with the local cell density I∞(r) and the locally dominant phenotypic state x¯∞(r) both given by (26). This
also implies that the local mean phenotypic state of the tumour cells at equilibrium, say X∞(r), coincides with
x¯∞(r), that is,
X∞(r) :=
1
I∞(r)
∫ 1
0
xn∞(r, x) dx = x¯∞(r).
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4 Numerical solutions
In this section, we construct numerical solutions to the system of equations (3) and (9). First, we describe
the setup of numerical simulations and the model parameterisation (Section 4.1). Then, we present a sample
of numerical solutions that confirm the results of the formal analysis of evolutionary dynamics carried out in
Section 3. We consider both the case of an arbitrary distribution of blood vessels (Section 4.2) and the case
where the blood vessel distribution is reconstructed from clinical images obtained via D-OCT (Section 4.3).
Finally, we use numerical solutions corresponding to increasing numbers of regularly distributed blood vessels
to investigate the existence of a possible relation between the degree of tumour tissue vascularisation and the
level of intratumour phenotypic heterogeneity (Section 4.4).
4.1 Setup of numerical simulations and model parameterisation
Building upon the modelling strategy presented in [62], we define the functions f(x) and g(x, s) that compose
the cell division rate p(x, s) as
f(x) := ϕ
[
1− (1− x)2
]
and g(x, s) := γ
s
µ+ s
(
1− x2), ϕ < γ. (28)
In (28), the parameters ϕ > 0 and γ > 0 model the maximum rate of cell division via anaerobic and aerobic
pathways, respectively, while µ > 0 is the Michaelis-Menten constant of oxygen. The assumption ϕ < γ is based
on empirical evidence indicating that higher levels of expression of hypoxia-inducible factors correlate with lower
rates of cell division [15, 16, 59]. Definitions (28) satisfy the general assumptions (6)-(8) and (13), and allow for
a detailed quantitative characterisation of the evolutionary dynamics of tumour cells based on the formal results
presented in Section 3. Moreover, they lead to an intratumour phenotypic fitness landscape R(x, I, s) that is
close to the approximate fitness landscapes which can be inferred from experimental data through regression
techniques [53, 72, 86]. In fact, substituting (28) into (5), after a little algebra we find
p(x, s) = a(s)− b(s) (x− h(s))2 , (29)
where
a(s) :=
γ s
µ+ s
+
ϕ2
ϕ+ γ
s
µ+ s
 , b(s) := (ϕ+ γ s
µ+ s
)
(30)
and
h(s) :=
ϕ
ϕ+ γ
s
µ+ s
. (31)
Here, a(s(t, r)) is the maximum fitness, h(s(t, r)) is the fittest phenotypic state and b(s(t, r)) is a nonlinear
selection gradient at position r and time t under the environmental conditions corresponding to the oxygen
concentration s(t, r).
We let the rate of inflow of oxygen through intratumour blood vessels to be constant in time and the same
for all vessels, i.e. we define the function S(t, r) in (10) as
S(t, r) ≡ Sv > 0. (32)
Moreover, we consider different definitions of the set ω which represent different distributions of the blood
vessels, as detailed in the next subsections. Unless otherwise explicitly stated, numerical simulations are carried
out using the parameter values listed in Table 1, which are chosen to be consistent with the existing literature.
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We choose Ω := [0,L]×[0,L] and use the notation r ≡ (r1, r2). We choose L = 0.5. Under the parameter choice
of Table 1, this value of L is equivalent to considering a square portion of a 2D cross-section of a vascularised
tumour of area 2.5×10−3 cm2. Moreover, we assume t ∈ [0,T] with the final time T corresponding to 365 days.
We complement (3) and (9) with the following initial conditions
n(0, r, x) = 108 e−
(x−0.5)2
0.1 ∀ r ∈ Ω and s(0, r) = S0 1ω(r), (33)
where S0 = 6.3996× 10−7 g cm−2 [52]. The initial conditions (33) correspond to a biological scenario whereby
at the initial time t = 0 tumour cells are uniformly distributed across Ω and are mainly in the intermediate
phenotypic state x = 0.5, while the oxygen is concentrated in correspondence of the blood vessels.
Numerical solutions are constructed using a uniform discretisation of the square [0,L]× [0,L] as the compu-
tational domain of the independent variable r and a uniform discretisation of the set [0, 1] as the computational
domain of the independent variable x. We also discretise the interval [0,T] with a uniform step. The method
for constructing numerical solutions to the system of equations (3) and (9) is based on an explicit finite differ-
ence scheme in which a three-point and a five-point stencils are used to approximate the diffusion terms in x
and r, respectively, and an explicit finite difference scheme is used for the reaction terms [56]. All numerical
computations are performed in Matlab.
Table 1: Parameter values used in numerical simulations
Parameter Biological meaning Value Reference
µ Michaelis-Menten constant of oxygen 1.5× 10−7 g cm−2 [19]
β Cell motility 10−13 cm2 s−1 [85, 92]
βs Oxygen diffusivity 2× 10−5 cm2 s−1 [43]
γ Maximum rate of cell division via aerobic pathways 1× 10−4 s−1 [19, 93]
κ Rate of cell death due to competition for space 2× 10−13 cm2 s−1 cells−1 [57, 62]
ηs Conversion factor for cell consumption of oxygen 2× 10−11 g cells−1 [19, 62]
α Rate of spontaneous phenotypic variations 10−13 s−1 [26, 28]
λs Rate of natural decay of oxygen 2.78× 10−6 s−1 [23]
ϕ Maximum rate of cell division via anaerobic pathways 1× 10−5 s−1 [41]
Sv Constant rate of inflow of oxygen through blood vessels 6.3996× 10−7 g cm−2 s−1 [52]
4.2 Numerical solutions corresponding to arbitrary blood vessel distributions
Substituting (29) into (26) gives the following expressions for the steady-state of the local cell density and of
the locally dominant phenotypic state
I∞(r) ≡ I∞(s∞(r)) = a(s
∞(r))
κ
and x¯∞(r) ≡ x¯∞(s∞(r)) = h(s∞(r)), (34)
where a(s∞) and h(s∞) are the maximum fitness and the fittest phenotypic state defined according to (30) and
(31), respectively.
In agreement with the results of the formal analysis of evolutionary dynamics carried out in Section 3 [cf.
the expression (27) of the steady-state local cell phenotypic distribution], the numerical results displayed in
Fig. 1 show that the cell density I(T, r) and the mean phenotypic state X(T, r), computed using the numerical
solution n(T, r, x) of (3), coincide with I∞(r) and x¯∞(r) computed through (34) choosing s∞(r) = s(T, r, x),
where s(T, r, x) is the numerical solution of (9). Moreover, the numerical solution n(T, r, x) is concentrated
as a sharp Gaussian-like function (data not shown) with maximum at the mean phenotypic state X(T, r) (vid.
insets in the fourth panels of Fig. 1).
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Figure 1: First row. Plots of the oxygen concentration s(T, r) (second panel), the cell density I(T, r) (third
panel) and the mean phenotypic state X(T, r) (fourth panel) obtained by solving numerically the system of
equations (3) and (9) subject to the initial conditions (33), with the set ω corresponding to the parts of Ω
highlighted in red in the first panel and with the parameters values given in Table 1. Second row. Plots of
the oxygen concentration s(T, r1, 0.4) (second panel), the cell density I(T, r1, 0.4) (third panel, blue line) and
the mean phenotypic state X(T, r1, 0.4) (fourth panel, blue line). The plot of the oxygen distribution s(T, r)
is displayed in the first panel, where the white, dashed line highlights the 1D cross-section corresponding to
r2 = 0.4. The red lines in the third and fourth panels highlight I
∞(r) and x¯∞(r) computed through (34)
choosing s∞(r) = s(T, r, x). The inset in the fourth panel displays the plot of the mean phenotypic state
X(T, r1, 0.4) (blue line) and of the maximum point of n(T, r1, 0.4, x) (green line). Third and fourth row.
Same as second row but for r2 = 0.2 (third row) and r2 = 0.07 (fourth row). The oxygen concentration s(T, r)
is in units of 10−7 g cm−2, the cell density I(T, r) is in units of 108 cells cm−2, and the spatial variables r1 and
r2 are in units of cm. The final time T was chosen such that the solutions of (3) and (9) are sufficiently close
to equilibrium at the end of numerical simulations. 9
The numerical results of Fig. 1, which refer to the blood vessel distribution displayed in the first panel of
the figure, indicate that the oxygen concentration is maximal in the vicinity of the blood vessels and decreases
monotonically with the distance from the blood vessels. Accordingly, the cell density is higher in the regions
in close proximity to the blood vessels and the mean phenotypic state increases from values close to x = 0 (i.e.
low levels of expression of the hypoxia-inducible factor) to values close to x = 1 (i.e. high levels of expression
of the hypoxia-inducible factor) moving away from the blood vessels. These results communicate the biological
notion that spatial inhomogeneities in the distribution of oxygen – which emerge spontaneously as a result of
the nonlinear interplay between the spatial distribution of the blood vessels, the reaction-diffusion dynamics of
oxygen and the consumption of oxygen by the cells – create environmental conditions that favour the selection
of cells with different phenotypic characteristics in different regions of vascularised tumours, thus leading to the
emergence and development of intratumour phenotypic heterogeneity.
4.3 Numerical solutions corresponding to blood vessel distributions reconstructed
from clinical images
The plots in Fig. 2 demonstrate that the qualitative behaviour of the numerical results in Fig. 1 remains
unchanged when spatial distributions of the intratumour blood vessels reconstructed from clinical images are
considered. These are the plots of the oxygen concentration s(T, r), the cell density I(T, r) and the mean
phenotypic state X(T, r) obtained by solving numerically the system of equations (3) and (9) with ω defined
according to the distributions of blood vessels provided by the clinical images displayed in the first column of
the figure, which were obtained via D-OCT and correspond to three cross sections of a malignant melanoma
at a depth of 0.02 cm (top panel), 0.03 cm (central panel) and 0.04 cm (bottom panel) from the surface of the
epidermis [80, Fig. 5]. These results also indicate that increasing levels of tumour vascularisation (from top to
bottom panel in the first column) lead to a more homogeneous spatial distribution of oxygen (second column),
which correlates with a more uniform cell density (third column) and a less diverse mean phenotypic state (fourth
column). This suggests the existence of a relationship between the level of tumour tissue vascularisation and
the level of intratumour phenotypic heterogeneity, which is systematically investigated in the next subsection.
4.4 Numerical solutions to assess the impact of tumour tissue vascularisation on
intratumour phenotypic heterogeneity
In order to systematically assess the impact of tumour tissue vascularisation on the level of intratumour pheno-
typic heterogeneity, we carry out numerical simulations considering increasing numbers of regularly distributed
blood vessels, which correspond to increasing values of the blood vessel density % defined as
% :=
|ω|
|Ω| . (35)
We quantify the level of intratumour phenotypic heterogeneity through the following continuum versions of
the equitability index E(t) (defined as a rescaled Shannon diversity index) and the Simpson diversity index
D(t) [83, 84]
E(t) := −
∫ 1
0
F (t, x) logF (t, x)
logN(t)
dx and D(t) :=
(∫ 1
0
F 2(t, x) dx
)−1
, (36)
where the total cell number N(t) and the fraction F (t, x) of cells in the phenotypic state x within the tumour
are defined according to (2).
The results obtained are summarised by the plots in Fig. 3, which display the equitability index and the
Simpson diversity index at the end of numerical simulations as functions of the blood vessel density %. Both
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Figure 2: First row. Plots of the oxygen concentration s(T, r) (second panel), the cell density I(T, r) (third
panel) and the mean phenotypic state X(T, r) (fourth panel) obtained by solving numerically the system
of equations (3) and (9) subject to the initial conditions (33), with the set ω reconstructed from the blood
vessel distribution provided by the clinical image displayed in the first panel, where the intratumoural vascular
network is highlighted in red, and with the parameters values given in Table 1 except for ηs = 2×10−10 g cell−1.
Second and third row. Same as first row but for a different clinical image. Clinical images are taken from [80,
Fig. 5(d-f)] under Creative Commons licence https://creativecommons.org/licenses/by-nc/4.0/. These
images correspond to three cross sections of a malignant melanoma at a depth of 0.02 cm (first row), 0.03 cm
(second row) and 0.04 cm (third row) from the surface of the epidermis. The oxygen concentration s(T, r) is in
units of 10−7 g cm−2, the cell density I(T, r) is in units of 108 cells cm−2, and the spatial variables r1 and r2
are in units of cm.
diversity indices are relatively low for low values of the blood vessel density, increase and reach a maximum value
for intermediate values of the blood vessel density – notice that both E(T) and D(T) attain their maximum
at the same value of % – and then decrease again for high values of the blood vessel density. This is due to
the fact that, as shown by the insets in Fig. 3: for low blood vessel densities the oxygen concentration s(T, r)
is uniformly low throughout Ω and, therefore, the mean phenotypic state X(T, r) is uniformly close to x = 1
(cf. the insets related to % = 0.4 × 10−3); for intermediate blood vessel densities the oxygen concentration is
more heterogeneously distributed and, as a consequence, the mean phenotypic state is more diverse (cf. the
insets related to % = 2.5 × 10−3); for high blood vessel densities the oxygen concentration is relatively high
throughout the tumour tissue and the mean phenotypic state is on average close to x = 0 (cf. the insets related
to % = 8.1× 10−3).
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Figure 3: Plots of the equitability index E(T) and the Simpson diversity index D(T) for different definitions
of the set ω characterised by different values of the blood vessel density % defined according to (35). The
equitability index and the Simpson diversity index are computed numerically through the formulas (36) using
the numerical solutions of the system of equations (3) and (9) subject to the initial conditions (33), with the
parameters values given in Table 1. The insets display sample plots of the oxygen distributions s(T, r) (top
panel) and the mean phenotypic state X(T, r) (bottom panel) corresponding to different values of %. The
Simpson diversity index D(T) is in units of 104, the blood vessel density % is in units of 10−4, the oxygen
concentration s(T, r) is in units of 10−7 g cm−2, and the spatial variables r1 and r2 are in units of cm.
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5 Conclusions and research perspectives
Intratumour phenotypic heterogeneity poses a major obstacle to anti-cancer therapy [17, 22, 40, 58, 67, 82]. It has
been hypothesised that the emergence of phenotypic heterogeneity among cancer cells within malignant tumours
is an eco-evolutionary process driven by spatial variations in the distribution of abiotic factors, which support
the creation of distinct ecological niches whereby cells with different phenotypic characteristics can be selected [3,
51, 66, 88]. In particular, oxygen is one of the key abiotic components of the tumour microenvironment that
are implicated in the emergence of intratumour phenotypic heterogeneity [40, 62, 88].
In this paper, we have carried out a mathematical study of the eco-evolutionary dynamics of tumour cells
within vascularised tumours. Our study is based on formal asymptotic analysis and numerical simulations of
a non-local PDE model that describes the phenotypic evolution of tumour cells and their nonlinear dynamic
interactions with oxygen, which is released from the intratumoural vascular network.
Our formal analytical results recapitulate the outcomes of previous theoretical and experimental studies on
intratumour phenotypic heterogeneity [5, 33, 40, 47] by providing a mathematical formalisation of the idea that
local variations in the oxygen concentration bring about local variations in the phenotypic fitness landscape of the
tumour, which ultimately result in a heterogeneous intratumour phenotypic composition. Numerical simulations
of the model corroborate this conclusion and show that local variations in the oxygen concentration, which are
orchestrated by nonlinear dynamic interactions between tumour cells and oxygen, promote the selection of cells
in different phenotypic states within the tumour depending on the distance from the blood vessels. In particular,
our results offer a theoretical basis for the biological evidence that regions of the tumour tissue in the vicinity
of blood vessels are densely populated by proliferative phenotypic variants, while poorly oxygenated regions are
sparsely populated by hypoxic phenotypic variants [73, 81, 88, 89].
Furthermore, the results of numerical simulations of the model establish a relation between the degree of tissue
vascularisation and the level of intratumour phenotypic heterogeneity, measured either as the equitability index
or the Simpson diversity index. This supports the idea that maps of the intratumour vascular network, which
can be reconstructed from clinical images obtained via non-invasive imagine techniques, such as D-OCT [54, 80]
and many others [6, 32, 42, 70, 73], could be clinically relevant, as they could be used to inform targeted
anticancer therapy [66, 77, 78, 90].
We conclude with a brief overview of possible research directions. In oder to disentangle and quantify the
impact of different evolutionary parameters on the emergence and development of intratumour phenotypic
heterogeneity, it would be useful to have exact solutions of (3) in the case where the intratumour phenotypic
fitness landscape is defined according to (4) and (29). This could be done by generalising the method developed
in [4, 20, 61] to construct exact solutions of non-local parabolic PDEs modelling the dynamics of well-mixed
phenotype-structured populations to the case where spatial structure is included.
Moreover, building upon the ideas presented in [7, 8], it would be interesting to study the effect on the
evolutionary dynamics of tumour cells of fluctuations in the rate of oxygen inflow, which are known to influence
intratumour phenotypic heterogeneity [38, 66, 79]. It would also be interesting to include the effect of temporal
variations in the spatial distribution of intratumoural blood vessels, which would make it possible to explore
the influence of angiogenesis on the eco-evolutionary dynamics of tumour cells in vascularised tumours. In
particular, it is a known fact that cancer cells in hypoxic conditions produce and secrete proangiogenic factors
which induce the formation of new blood vessels departing from existing ones. In addition, our model could
be developed to incorporate a more comprehensive description of cell metabolism that captures acidosis and
enhanced tumour invasiveness caused by the presence of hypoxic cells [34, 35, 39, 51, 65, 69, 96].
Finally, we plan to extend the model considered here to carry out a mathematical study of the eco-evolutionary
dynamics of tumour cells in metastatic tumours. In this respect, a modelling approach analogous to the
one presented in [31], whereby different metastatic sites are represented as distinct compartments and the
metastatisation process is modelled by allowing tumour cells to transition from one site to another through the
intratumour blood vessels seen as entry/exit locations, may prove useful.
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